Ipramist 250mcg Solution for inhalation
Prescription Required
Product introduction
Ipramist 250mcg Solution for inhalation is an anticholinergic medicine. It is used in the treatment of chronic obstructive pulmonary disease and asthma. It relaxes the muscles of your airways and eases symptoms such as chest tightness, shortness of breath, wheezing, and coughing
Ipramist 250mcg Solution for inhalation is known as bronchodilator and is used to treat breathing difficulties due to chest tightness and shortness of breath.
Ipramist 250mcg Solution for inhalation is known as bronchodilator and is used to treat breathing difficulties due to chest tightness and shortness of breath.
Uses of Ipramist Solution for inhalation
Benefits of Ipramist Solution for inhalation
In Treatment of Chronic obstructive pulmonary disease (COPD)
Ipramist 250mcg Solution for inhalation helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.
Side effects of Ipramist Solution for inhalation
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ipramist
- Headache
- Dizziness
- Throat irritation
- Cough
- Dryness in mouth
- Nausea
How to use Ipramist Solution for inhalation
Use it as advised by your doctor or check the label for directions before use.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Ipramist 250mcg Solution for inhalation. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Ipramist 250mcg Solution for inhalation is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Ipramist 250mcg Solution for inhalation is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Ipramist 250mcg Solution for inhalation
₹31.13/Solution for inhalation
Ipneb Solution for inhalation
Lupin Ltd
₹42.38/solution for inhalation
36% costlier
Quick tips
- Ipramist 250mcg Solution for inhalation makes breathing easier for patients with chronic obstructive pulmonary disease (COPD) and asthma.
- It does not work right away and should not be used to relieve sudden breathing problems. Use your rescue inhaler to control sudden difficulty in breathing.
- Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
- Gargle with warm water after each inhalation to avoid any fungal infections in your mouth and throat.
- Take the first dose under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
- Your doctor may monitor your blood potassium level regularly while taking this medication.
- Only small amounts of Ipramist 250mcg Solution for inhalation may get absorbed into the bloodstream after inhalation. Hence, serious side effects are unlikely.
Fact Box
Chemical Class
Atropine Derivative
Habit Forming
No
Therapeutic Class
RESPIRATORY
Action Class
Anticholinergic - COPD
Patient concerns
FAQs
Q. Is Ipramist 250mcg Solution for inhalation a steroid?
No, Ipramist 250mcg Solution for inhalation is not a steroid.
Q. Is Ipramist 250mcg Solution for inhalation a narcotic?
No, Ipramist 250mcg Solution for inhalation is not a narcotic.
Q. Does it contain opium?
It does not contain opium or its derivative.
Q. Does Ipramist 250mcg Solution for inhalation cause weight gain?
Ipramist 250mcg Solution for inhalation has no known effects on weight gain.
Q. Does Ipramist 250mcg Solution for inhalation cause constipation?
Yes, constipation is a known side effect of Ipramist 250mcg Solution for inhalation.
Q. Does Ipramist 250mcg Solution for inhalation cause tachycardia (increased heart rate)?
Ipramist 250mcg Solution for inhalation may sometimes cause tachycardia (increased heart rate) in some patients. It is not a common side effect of Ipramist 250mcg Solution for inhalation.
Q. Does Ipramist 250mcg Solution for inhalation cause an increase in blood pressure?
Ipramist 250mcg Solution for inhalation has no known effects on blood pressure.
Q. Is ipratropium bromide the same as albuterol?
Ipratropium bromide and albuterol are 2 different medicines. They have the same action. They relax the air passages and make breathing easier (bronchodilators).
Q. Is ipratropium bromide the same as budesonide?
Ipratropium/ipratropium bromide and budesonide belong to different class of medicines but both are used either alone or in combination to treat bronchitis, asthma, and associated conditions.
Q. Is Ipramist 250mcg Solution for inhalation bromide a bronchodilator?
Yes, Ipramist 250mcg Solution for inhalation/ Ipramist 250mcg Solution for inhalation bromide is a bronchodilator used to treat bronchitis, asthma, and associated conditions.
Q. Is Ipramist 250mcg Solution for inhalation bromide a long acting bronchodilator?
No, Ipramist 250mcg Solution for inhalation/ Ipramist 250mcg Solution for inhalation bromide is a short-acting bronchodilator.
Q. Is Ipramist 250mcg Solution for inhalation bromide an antihistaminic/antibiotic or is it an anticholinergic?
Ipramist 250mcg Solution for inhalation is neither antihistamine nor an antibiotic. It belongs to a class of anticholinergic bronchodilators.
Q. Is Ipramist 250mcg Solution for inhalation bromide a short-acting anticholinergic?
Yes, Ipramist 250mcg Solution for inhalation/ Ipramist 250mcg Solution for inhalation bromide is a short-acting anticholinergic bronchodilator.
Q. Is Ipramist 250mcg Solution for inhalation safe for infants?
Yes, Ipramist 250mcg Solution for inhalation is safely used in infants. Patients should follow the advice of the doctor regarding its use.
Q. Is Ipramist 250mcg Solution for inhalation bromide a rescue inhaler?
No, Ipramist 250mcg Solution for inhalation is a bronchodilator for the maintenance treatment of bronchospasm. It is not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required.
Q. Can Ipramist 250mcg Solution for inhalation bromide used alone?
Yes, Ipramist 250mcg Solution for inhalation bromide can be used alone as maintenance therapy in the treatment of bronchospasm, asthma, and other associated conditions.
Q. Does Ipramist 250mcg Solution for inhalation bromide expire?
Yes, Ipramist 250mcg Solution for inhalation bromide formulations have an expiry date. Please Read the details on the package for the correct expiry date.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Brown JH, Laiken N. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 230-31.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 734.
- Ipratropium. Bracknell Berkshire: Boehringer Ingelheim Limited; 2004 [revised Feb. 2018]. [Accessed 01 Apr. 2019] (online) Available from:
- Drugs.com. Ipratropium Pregnancy and Breastfeeding Warnings. [Accessed 01 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹31.13
Inclusive of all taxes
15.0 ml in 1 bottle
SOLD OUT
Notify me